Literature DB >> 17703939

A novel Angiogenin gene mutation in a sporadic patient with amyotrophic lateral sclerosis from southern Italy.

F L Conforti1, T Sprovieri, R Mazzei, C Ungaro, V La Bella, A Tessitore, A Patitucci, A Magariello, A L Gabriele, G Tedeschi, I L Simone, G Majorana, P Valentino, F Condino, F Bono, M R Monsurrò, M Muglia, A Quattrone.   

Abstract

Mutations in the Angiogenin gene (ANG) linked to 14q11.2 have been recently discovered to be associated with Amyotrophic Lateral Sclerosis (ALS) in Irish and Scottish populations. In our study we investigated the role of ANG gene in ALS patients from southern Italy. We found a novel mutation in the signal peptide of the ANG gene in a sporadic patient with ALS (SALS). The molecular analysis of the ANG gene also demonstrated an allelic association with the rs11701 single nucleotide polymorphism (SNP) in familial ALS (FALS) but not in SALS patients. Our finding supports the evidence that the ANG gene is involved in ALS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703939     DOI: 10.1016/j.nmd.2007.07.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  29 in total

Review 1.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

Review 2.  Lack of association between the Angiogenin (ANG) rs11701 polymorphism and amyotrophic lateral sclerosis risk: a meta-analysis.

Authors:  Li-Shou Pan; Xin-Bo Deng; Zheng Wang; Hui-Lin Leng; Xue-Peng Zhu; Dan Ding
Journal:  Neurol Sci       Date:  2016-01-11       Impact factor: 3.307

Review 3.  Transgenic animal models of neurodegeneration based on human genetic studies.

Authors:  Brandon K Harvey; Christopher T Richie; Barry J Hoffer; Mikko Airavaara
Journal:  J Neural Transm (Vienna)       Date:  2010-10-08       Impact factor: 3.575

4.  Association between the Angiogenin (ANG) K17I variant and amyotrophic lateral sclerosis risk in Caucasian: a meta-analysis.

Authors:  Lishou Pan; Xinbo Deng; Dan Ding; Huilin Leng; Xuepeng Zhu; Zheng Wang
Journal:  Neurol Sci       Date:  2015-08-09       Impact factor: 3.307

Review 5.  Targeting angiogenin in therapy of amyotropic lateral sclerosis.

Authors:  Hiroko Kishikawa; David Wu; Guo-fu Hu
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

Review 6.  Vitamin D as a potential therapy in amyotrophic lateral sclerosis.

Authors:  Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2014-02       Impact factor: 5.243

7.  Extensive genetics of ALS: a population-based study in Italy.

Authors:  Adriano Chiò; Andrea Calvo; Letizia Mazzini; Roberto Cantello; Gabriele Mora; Cristina Moglia; Lucia Corrado; Sandra D'Alfonso; Elisa Majounie; Alan Renton; Fabrizio Pisano; Irene Ossola; Maura Brunetti; Bryan J Traynor; Gabriella Restagno
Journal:  Neurology       Date:  2012-10-24       Impact factor: 9.910

8.  Characterization of the angiogenic activity of zebrafish ribonucleases.

Authors:  Daria M Monti; Wenhao Yu; Elio Pizzo; Kaori Shima; Miaofen G Hu; Chiara Di Malta; Renata Piccoli; Giuseppe D'Alessio; Guo-Fu Hu
Journal:  FEBS J       Date:  2009-06-22       Impact factor: 5.542

9.  Ribonuclease/angiogenin inhibitor 1 regulates stress-induced subcellular localization of angiogenin to control growth and survival.

Authors:  Elio Pizzo; Carmen Sarcinelli; Jinghao Sheng; Sabato Fusco; Fabio Formiggini; Paolo Netti; Wenhao Yu; Giuseppe D'Alessio; Guo-Fu Hu
Journal:  J Cell Sci       Date:  2013-07-10       Impact factor: 5.285

10.  Identification of novel Angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosis.

Authors:  Rubén Fernández-Santiago; Sabine Hoenig; Peter Lichtner; Anne-Dorte Sperfeld; Manu Sharma; Daniela Berg; Oliver Weichenrieder; Thomas Illig; Katharina Eger; Thomas Meyer; Johanna Anneser; Christoph Münch; Stephan Zierz; Thomas Gasser; Albert Ludolph
Journal:  J Neurol       Date:  2009-04-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.